S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ORGO Organogenesis Holdings Inc

2.28

-0.03 (-1.30%)

May 09 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Organogenesis (NASDAQ:ORGO)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Organogenesis Charts.

Organogenesis (NASDAQ:ORGO)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Organogenesis Charts.

Organogenesis Holdings Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (9 hours ago) • Edgar (US Regulatory)

Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
Thursday 9 May 2024 (9 hours ago) • GlobeNewswire Inc.

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
Thursday 2 May 2024 (1 week ago) • GlobeNewswire Inc.

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Tuesday 16 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
Wednesday 3 April 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (3 months ago) • Edgar (US Regulatory)

More Organogenesis Holdings Inc News Articles

Emergent Health (PK)

ProText Mobility (PK)

Music Licensing (PK)

GNCC Capital (CE)

NaturalShrimp (QB)

Ecare Solutions (PK)

Ronn Motor (PK)

Brookmount Explorations (PK)

Clean Vision (QB)

Yuenglings Ice Cream (PK)

Innovation Pharmaceuticals (CE)

Globestar Therapeutics (PK)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions